AGENDA

  • All
  • MONDAY, OCTOBER 27, 2025
  • TUESDAY, OCTOBER 28, 2025
  • WEDNESDAY, OCTOBER 29, 2025
8:00 a.m. – 4:30 p.m.
Registration
8:00 a.m. – 9:00 a.m.
Networking Breakfast
9:00 a.m. – 9:10 a.m.
Welcome and Introduction

John Murphy III
President & CEO, AAM

9:10 a.m. – 9:45 a.m.
General Session
9:45 a.m. – 10:15 a.m.
OGD Keynote Address

Iilun Murphy, M.D.
Director, Office of Generic Drugs (OGD), CDER, FDA

10:15a.m. – 10:45 a.m.
Networking Break
10:45 a.m. – Noon
GRx+Biosims Learning Tracks
12:00 p.m. – 1:15 p.m.
Networking Luncheon
1:15 p.m. – 2:30 p.m.
GRx+Biosims Learning Tracks
2:30 p.m. – 2:45 p.m.
Networking Break
2:45 p.m. – 4:00 p.m.
GRx+Biosims Learning Tracks
4:00 p.m. – 5:00 p.m.
Networking Reception
8:00 a.m. – 9:00 a.m.
Networking Breakfast
8:00 a.m. – 9:00 a.m.
Biosimilars Council Meeting (members only)
9:00 a.m. – 10:30 a.m.
General Sessions
10:30 a.m. – 11:00 a.m.
Networking Break
11:00 a.m. – 12:15 p.m.
GRx+Biosims Learning Tracks
12:15 p.m. – 1:30 p.m.
Networking Lunch
1:30 p.m. – 2:45 p.m.
GRx+Biosims Learning Tracks
2:45 p.m. – 3:00 p.m.
Networking Break
3:00 p.m. – 5:00 p.m.
GRx+Biosims Roundtable
5:00 p.m. – 6:00 p.m.
Networking Reception
6:00 p.m. – 8:00 p.m.
Dinner & Entertainment
7:30 a.m. – 8:30 a.m.
Networking Breakfast
7:30 a.m. – 8:30 a.m.
Science and Regulatory Working Group (members only)
8:30 a.m. – 10:15 a.m.
General Sessions
10:15 a.m. – 10:30 a.m.
Networking Break
10:30 a.m. – 11:30 a.m.
Global and U.S. Generics and Biosimilars: Trends, Issues and Outlook

Scott Biggs
Director, Supplier Services, IQVIA

11:30 a.m. – 12:30 p.m.
Panel Discussion
12:30 p.m. – 1:00 p.m.
CDER Keynote Address

Jacqueline Corrigan-Curay, JD, M.D.
Acting Director, Center for Drug Evaluation and Research (CDER), FDA

1:00 p.m.
Closing Remarks

John Murphy III
President & CEO, AAM

1:00 p.m. – 2:00 p.m.
Farewell Luncheon – Grab + Go
2:00 p.m.
Conference Concludes

*Agenda is subject to change